LAURINI, ERIK

LAURINI, ERIK  

Dipartimento di Ingegneria e Architettura  

Docenti di ruolo di IIa fascia  

Mostra records
Risultati 1 - 20 di 195 (tempo di esecuzione: 0.005 secondi).
Titolo Data di pubblicazione Autori File
2-Aryl-3-(1H-azol-1-yl)-1H-indole derivatives: a new class of antimycobacterial compounds. Convetional heating in comparison with MW-assisted synthesis. 1-gen-2009 ZAMPIERI, DANIELEMAMOLO, MARIA GRAZIALAURINI, ERIKSCIALINO, GiudittaBANFI, ELENAVIO, LUCIANO
2-Difluoromethylene-4-methylenepentanoic Acid, A Paradoxical Probe Able To Mimic the Signaling Role of 2-Oxoglutaric Acid in Cyanobacteria 1-gen-2011 LAURINI, ERIKPOSOCCO, PAOLAFERMEGLIA, MAURIZIOPRICL, SABRINA +
3-Aryl-2-[1H-benzotriazol-1-yl]acrylonitriles: A novel class of potent tubulin inhibitors 1-gen-2011 LAURINI, ERIKPANENI, Maria SilviaPOSOCCO, PAOLAFERMEGLIA, MAURIZIOPRICL, SABRINA +
3-Piperidin-4-yl-methyl-3H-benzoxazol-2-one derivatives as sigma ligands. 1-gen-2007 MAMOLO, MARIA GRAZIAZAMPIERI, DANIELELAURINI, ERIKVIO, LUCIANOFLORIO, CHIARA +
3D Homology Model of Sigma1 Receptor 1-gen-2017 LAURINI, ERIKMARSON, DOMENICOFERMEGLIA, MAURIZIOPRICL, SABRINA
9-Aminoacridine-based agents impair the bovine viral diarrhea virus (BVDV) replication targeting the RNA-dependent RNA polymerase (RdRp) 1-gen-2018 Laurini, ErikBoccardo, SilviaAulic, SuzanaFermeglia, MaurizioPricl, Sabrina +
[18F]Fluspidine—A PET Tracer for Imaging of σ1 Receptors in the Central Nervous System 1-gen-2024 Erik LauriniSabrina Pricl +
A 3D-Pharmacophore Model for σ2 Receptors Based on a Series of Substituted Benzo[d]oxazol-2(3H)-one Derivatives 1-gen-2010 LAURINI, ERIKZAMPIERI, DANIELEMAMOLO, MARIA GRAZIAVIO, LUCIANOZANETTE, CATERINAFLORIO, CHIARAPOSOCCO, PAOLAFERMEGLIA, MAURIZIOPRICL, SABRINA
A combined in silico/in vitro approach unveils common molecular requirements for efficient BVDV RdRp binding of linear aromatic N-polycyclic systems 1-gen-2016 LAURINI, ERIKFERMEGLIA, MAURIZIOPRICL, SABRINA +
A dual targeting dendrimer-mediated siRNA delivery system for effective gene silencing in cancer therapy 1-gen-2018 Erik LauriniDomenico MarsonSabrina Pricl +
A methodology for the sustainability evaluation of industrial pharmaceutical processes 1-gen-2015 MIO, ANDREALAURINI, ERIKPRICL, SABRINAFERMEGLIA, MAURIZIO
A Molecular Dynamics approach to investigate the tribological behaviour of Al-Si and α-Al2O3-Si interfaces at the nanoscale 1-gen-2022 Mio, A.Marson, D.Laurini, E.Pricl, S.Fermeglia, M. +
A new class of substituted benzo[d]oxazole-2(3H)-one derivatives as sigma1 ligands. 1-gen-2008 MAMOLO, MARIA GRAZIAZAMPIERI, DANIELELAURINI, ERIKVIO, LUCIANOFLORIO, CHIARA +
A new frontier for modeFRONTIER: an orchestrator for molecular simulation symphony 1-gen-2013 LAURINI, ERIKFERMEGLIA, MAURIZIOPRICL, SABRINA
A self-assembling amphiphilic dendrimer nanotracer for SPECT imaging 1-gen-2019 Laurini E.Marson D.Pricl S. +
A self-assembling prodrug nanosystem to enhance metabolic stability and anticancer activity of gemcitabine 1-gen-2022 Laurini E.Pricl S. +
A step forward in the sigma enigma: a role for chirality in the sigma1 receptor–ligand interaction? 1-gen-2015 LAURINI, ERIKFERMEGLIA, MAURIZIOPRICL, SABRINA +
An ionizable supramolecular dendrimer nanosystem for effective siRNA delivery with a favorable safety profile 1-gen-2021 Laurini E.Marson D.Pricl S. +
Analysis of the molecular interactions of the potent analgesic S1RA with the σ1 receptor 1-gen-2013 LAURINI, ERIKDAL COL, VALENTINAPRICL, SABRINA +
Anomerization of Acrylated Glucose during Traveling Wave Ion Mobility Spectrometry 1-gen-2015 POSOCCO, PAOLALAURINI, ERIKPRICL, SABRINA +